Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs.
- 8 December 1979
- Vol. 2 (6203) , 1461-1466
- https://doi.org/10.1136/bmj.2.6203.1461
Abstract
A collaborative study including centres in the United Kingdom, Australia, and New Zealand was instituted in 1970 to determine the incidence of cancer in patients treated for at least three months with azathioprine, cyclophosphamide, or chlorambucil. Follow-up of 3823 renal transplant recipients showed an almost 60-fold increase of non-Hodgkin's lymphoma together with an excess of squamous-cell skin cancer and mesenchymal tumours. A series of 1349 patients without transplants showed an excess of the same tumours, though to a less extent. These preliminary findings provide no clear evidence that immunosuppressive drugs produce the increased risk of most of the common cancers that might be expected from the simplest interpretation of impaired "immunosurveillance."Keywords
This publication has 11 references indexed in Scilit:
- Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritisJournal of Chronic Diseases, 1978
- Carcinoma of the Urinary Bladder in Patients Receiving CyclophosphamideNew England Journal of Medicine, 1975
- Multiple Sclerosis: Reticulum Cell Sarcoma of the Nervous System in a Patient Treated with Immunosuppressive DrugsEuropean Neurology, 1974
- Intracranial reticulum cell sarcoma associated with immunoglobulin A deficiencyJournal of Neurology, Neurosurgery & Psychiatry, 1973
- SKIN CANCER AND IMMUNOSUPPRESSIONThe Lancet, 1971
- Immunosurveillance and cancer: epidemiological evidence.BMJ, 1970
- Malignant lymphomas in transplantation patients.1969
- Reticulum Cell Sarcoma after Renal Homotransplantation and Azathioprine and Prednisone TherapyBMJ, 1968
- Transitional Cell Tumors of the Renal Pelvis in Analgesic AbusersScandinavian Journal of Urology and Nephrology, 1968
- Somatic Mutation and Chronic DiseaseBMJ, 1965